Skip to main content

Table 3 Possible causes of non-adherence to the guidelines evaluated and transferral for analysis

From: Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study

Patient answer Transferred to Physician answer Transferred to
I do not know I do not know I do not know Falsely not indicated GP
I do not need it I do not need it Not indicated  
I do not want it I do not want it Noncompliance Noncompliance
   Avoidance of polypharmacy Avoidance of polypharmacy
   Specialist did not prescribe it Falsely not indicated s/h*
I do not take it any more Adverse drug event Contraindication Contraindication
  Falsely discontinued Patient does not take it anymore Adverse drug event
    Falsely discontinued
  (or one of the above)   (or one of the above)
Other Allocation to one of the above Other Allocation to one of the above
  1. * Falsely not indicated specialist / hospital (when a certain therapy was not initiated or recommended by specialists or physicians in the hospital, and the GP adhered to this recommendation even though in fact there was an indication for the drug).
  2. Defined as a stop of treatment triggered by the physician despite guidelines recommending a continuation of the therapy (e.g. discontinuation of statin therapy after reaching target values for LDL-cholesterol which then rose above target again).